Managing type 2 diabetes requires a dependable and clinically proven therapy that keeps blood glucose levels stable throughout the day. SitaRA-M 100mg/500mg Tablet PR is a powerful dual-action formulation designed to provide sustained glycemic control with the combined benefits of Sitagliptin and Metformin. As a trusted Superintendent Pharmacist in the USA, I recommend this advanced prolonged-release tablet to patients who need consistent blood sugar support without frequent dosing. Its long-acting profile helps simplify daily diabetes care while keeping you in control of your health.

SitaRA-M 100mg/500mg Tablet PR works by targeting multiple pathways involved in glucose regulation. This includes enhancing insulin secretion, reducing glucose production in the liver, and improving insulin sensitivity. By utilizing two well-established antidiabetic agents, the tablet ensures better glycemic stability while reducing fluctuations that commonly affect individuals living with type 2 diabetes. Patients often appreciate that this PR (prolonged-release) formulation provides smoother absorption and fewer gastrointestinal disturbances compared to standard formulations.

What is SitaRA-M 100mg/500mg Tablet PR(Sitagliptin 100mg + Metformin 500mg)?

When you choose SitaRA-M 100mg/500mg TabletPR, you are choosing a therapy built for safety, effectiveness, and convenience. Sitagliptin helps increase incretin hormone levels, enabling your body to release insulin more efficiently after meals. At the same time, Metformin helps reduce excessive sugar production in the liver while enhancing the uptake of glucose by body tissues. The result is a balanced and controlled blood sugar profile throughout the day.

This medicine is suitable for adults diagnosed with type 2 diabetes who require combination therapy to maintain glycemic control. It is typically recommended when single-agent therapy (like Metformin alone) does not provide adequate results. As a clinically accepted and widely used therapy, SitaRA-M 100mg/500mg TabletPR plays a crucial role in preventing long-term diabetes-related complications when used alongside a healthy diet and regular exercise.

One of the major advantages of the prolonged-release technology in SitaRA-M 100mg/500mg TabletPR is its ability to maintain steady drug levels in the bloodstream. This avoids sudden peaks and troughs associated with conventional formulations, offering better tolerance and improved patient compliance. Many patients find that the once-daily dosing schedule helps them adhere to their treatment plan more consistently.

Key Features and Benefits

1. Dual-Action Glucose Control

The combination of Sitagliptin and Metformin provides comprehensive glucose regulation by addressing multiple metabolic pathways simultaneously. This ensures better fasting and post-meal sugar balance.

2. Prolonged-Release Technology

SitaRA-M 100mg/500mg TabletPR releases its active ingredients gradually, promoting smoother glycemic control throughout the day and reducing digestive discomfort.

3. Improved Insulin Efficiency

The Sitagliptin component enhances incretin hormones, helping your pancreas respond more efficiently to glucose spikes.

4. Reduced Liver Glucose Output

Metformin helps minimize hepatic glucose production, which is crucial for lowering fasting blood sugar.

5. Supports Weight Management

Metformin is known for its weight-neutral or weight-supportive effects, making this combination beneficial for individuals concerned about weight gain often associated with diabetes treatment.

6. Convenient Once-Daily Dosage

The prolonged-release version ensures patient-friendly dosing, improving adherence and long-term management success.

Related Product

Sitara DM 10mg/500mg/100mg Tablet

Sitara-D 100mg/10mg Tablet

Sitara 100mg Tablet

SitaRA-M 50mg/500mg Tablet ER

SitaRA-M 100mg/500mg TabletPR

Sitara DM 10mg/1000mg/100mg Tablet

Sitara-PM 500mg Tablet SR

SitaRA 50mg Tablet

SitaRA-M 50mg/1000mg Tablet ER

SitaRA-M 100mg/1000mg Tablet ER

Sitara-D 5mg/100mg Tablet

Sitara-D 10mg/50mg Tablet

Sitara-D 50mg/5mg Tablet

Sitara PM 1000mg/15mg/100mg Tablet

How SitaRA-M 100mg/500mg Tablet PR Works

When you take SitaRA-M 100mg/500mg TabletPR, Sitagliptin works by inhibiting the DPP-4 enzyme, which naturally breaks down incretin hormones. By blocking this enzyme, Sitagliptin boosts incretin levels, enabling natural insulin release and reducing glucagon production. This keeps blood sugar in check, particularly after meals.

Metformin complements this mechanism by lowering hepatic glucose output and improving peripheral insulin sensitivity. Together, the result is controlled and balanced blood sugar, reduced complications, and improved metabolic health.

Who Should Use SitaRA-M 100mg/500mg Tablet PR?

This medication is suitable for adults with type 2 diabetes who:

• Need additional glycemic control beyond lifestyle changes
• Do not achieve target blood-glucose levels with Metformin alone
• Prefer a once-daily prolonged-release formulation
• Require a combination therapy for long-term diabetes management

Always follow your physician’s recommendation when initiating or adjusting your antidiabetic therapy.

Precautions

While SitaRA-M 100mg/500mg TabletPR is effective, patients should keep the following in mind:

• Not recommended for individuals with severe kidney impairment
• Avoid alcohol as it increases the risk of lactic acidosis
• Inform your doctor if you experience unusual fatigue, muscle pain, or abdominal discomfort
• Monitor your blood sugar regularly
• Take the tablet with food to prevent gastric irritation

Why Order From Us?

We provide 100% authentic medicines at competitive prices. Each purchase of SitaRA-M 100mg/500mg TabletPR is securely packaged, promptly delivered, and backed by professional pharmaceutical guidance. Click now to order your supply and manage your diabetes with confidence.